Krahasoni metodat

	Eksperiment i përshtatshëm me kryqëzim	Gjyqi i Kontrolluar Randomizuar me Kalim (Crossover Randomized Controlled Trial)
Fusha	Dizajni eksperimental	Dizajni eksperimental
Familja	Process / pipeline	Process / pipeline
Viti i origjinës	Late 1990s–2000s	1960s (Grizzle 1965 for statistical foundations); widely used in clinical research since the 1970s
Krijuesi	Developed through convergence of crossover trial methodology (Senn, Williams) and adaptive design methods (Bauer, Köhne, Chow, Chang)	Early formalized by statisticians including Bradford Hill and colleagues in clinical trials; theoretical framework developed by Grizzle (1965) and later Senn (2002)
Lloji	Experimental design — hybrid adaptive/crossover	Experimental within-subject design
Burimi themelues	Chow, S.-C., & Chang, M. (2008). Adaptive Design Methods in Clinical Trials. Chapman & Hall/CRC. ISBN: 978-1584888468	Senn, S. (2002). Cross-over Trials in Clinical Research (2nd ed.). Wiley. ISBN: 978-0471496533
Emërtime të tjera	adaptive crossover trial, adaptive crossover design, crossover adaptive trial, ACE design	crossover RCT, crossover trial, within-subject RCT, AB/BA crossover design
Të lidhura	5	5
Përmbledhja	An adaptive crossover experiment combines the within-subject efficiency of crossover designs — where each participant receives multiple treatments in sequence — with pre-specified adaptive rules that allow trial parameters to be modified based on interim data. Each participant acts as their own control across treatment periods, while ongoing accumulating evidence can trigger pre-planned changes such as sample size re-estimation, treatment arm dropping, or allocation ratio adjustment, all governed by a formal adaptation plan to preserve inferential validity.	A crossover randomized controlled trial (crossover RCT) is an experimental design in which each participant receives all study interventions in a randomized sequence, separated by a washout period. Because every participant serves as their own control, within-subject variability is eliminated from the treatment comparison, yielding greater statistical power per participant than a parallel-group RCT of equal size.